ArticleClinical & translational immunology2021
Erratum: Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma.
Rebecca C Abbott et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.